Hexavest’s GSK GSK Stock Holding History

Hexavest’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-769	Closed	-$41K	–	449
2019 Q3	$41K	Hold	769	–	–	﹤0.01%	337
2019 Q2	$38K	Hold	769	–	–	﹤0.01%	345
2019 Q1	$40K	Hold	769	–	–	﹤0.01%	326
2018 Q4	$37K	Hold	769	–	–	﹤0.01%	300
2018 Q3	$39K	Hold	769	–	–	﹤0.01%	350
2018 Q2	$39K	Hold	769	–	–	﹤0.01%	352
2018 Q1	$38K	Hold	769	–	–	﹤0.01%	384
2017 Q4	$34K	Hold	769	–	–	﹤0.01%	417
2017 Q3	$39K	Hold	769	–	–	﹤0.01%	402
2017 Q2	$41K	Hold	769	–	–	﹤0.01%	394
2017 Q1	$41K	Hold	769	–	–	﹤0.01%	394
2016 Q4	$37K	Hold	769	–	–	﹤0.01%	400
2016 Q3	$41K	Hold	769	–	–	﹤0.01%	400
2016 Q2	$42K	Hold	769	–	–	﹤0.01%	412
2016 Q1	$39K	Hold	769	–	–	﹤0.01%	401
2015 Q4	$39K	Hold	769	–	–	﹤0.01%	394
2015 Q3	$37K	Hold	769	–	–	﹤0.01%	392
2015 Q2	$40K	Hold	769	–	–	﹤0.01%	397
2015 Q1	$44K	Hold	769	–	–	﹤0.01%	377
2014 Q4	$41K	Hold	769	–	–	﹤0.01%	377
2014 Q3	$44K	Hold	769	–	–	﹤0.01%	381
2014 Q2	$51K	Hold	769	–	–	﹤0.01%	370
2014 Q1	$51K	Hold	769	–	–	﹤0.01%	366
2013 Q4	$51K	Hold	769	–	–	﹤0.01%	313
2013 Q3	$48K	Hold	769	–	–	﹤0.01%	321
2013 Q2	$48K	Buy	+769	New	+$48.8K	﹤0.01%	320

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Hexavest's GSK Position: Q4 2019 in Review

Hexavest sold out of GSK (GSK) in Q4 2019, closing a stake of 769 shares — an estimated $41K sold.

Hexavest first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $51K in Q2 2014. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Hexavest reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Hexavest sold 769 GSK shares in Q4 2019, an estimated $41K.
Hexavest first reported a position in GSK in Q2 2013 and held it in 26 quarters.
Hexavest's GSK position peaked at $51K in Q2 2014.
895 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Hexavest's 13F filing for Q4 2019, filed 9 Jan 2020.